• Western blot of rat hippocampal lysate showing specific immunolabeling of the ~100 kDa GluR1 protein phosphorylated at Ser845 in the first lane (-). Phosphospecificity is shown in the second lane (+) where immunolabeling is completely eliminated by blot treatment with lambda phosphatase ( Lambda-Ptase, 1200 units for 30 min).
  • Effects of striatal slice treatment with NMDA (25 Mu M, 5 min) , dopamine (DA, 10 Mu M, 15 min) , or both on PKA-dependent phosphorylation of Ser845 GluR1 (top) and Thr34 DARPP-32 (bottom). Image from publication CC-BY-4. 0. PMID: 35835216

Anti-Phospho-GRIA1-Ser845 antibody (STJA0003662)

SKU:
STJA0003662-150

Shipping:
Free Shipping
Current Stock:
Host: Rabbit
Applications: WB/IHC
Reactivity: Mouse/Rat/Human/Non-Human Primates
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-Phospho-GluR1-Ser845 is suitable for use in Western Blot and Immunohistochemistry research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: 100 µl in 10 mM HEPES (pH 7.5) , 150 mM NaCl, 100 µg per ml BSA and 50% Glycerol.
Purification: This antibody was antigen affinity purified from pooled serum.
Dilution Range: WB 1:1000
IHC 1:1000
ICC
IP
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: Gria1
Gene ID: 50592
Uniprot ID: GRIA1_RAT
Immunogen: Synthetic phospho-peptide corresponding to amino acid residues surrounding Ser845 conjugated to KLH.
Tissue Specificity Detected in cerebellum (at protein level).
Post Translational Modifications Palmitoylated. Depalmitoylated upon glutamate stimulation. Cys-603 palmitoylation leads to Golgi retention and decreased cell surface expression. In contrast, Cys-829 palmitoylation does not affect cell surface expression but regulates stimulation-dependent endocytosis. Phosphorylated at Ser-645. Phosphorylated at Ser-710 by PKC. Phosphorylated at Ser-849 by PKC, PKA and CAMK2. Phosphorylated at Ser-863 by PKC, PKA and PRKG2. Phosphorylation of Ser-863 is reduced by induction of long-term depression and increased by induction of long-term potentiation.
Function Ionotropic glutamate receptor. L-glutamate acts as an excitatory neurotransmitter at many synapses in the central nervous system. Binding of the excitatory neurotransmitter L-glutamate induces a conformation change, leading to the opening of the cation channel, and thereby converts the chemical signal to an electrical impulse. The receptor then desensitizes rapidly and enters a transient inactive state, characterized by the presence of bound agonist. In the presence of CACNG4 or CACNG7 or CACNG8, shows resensitization which is characterized by a delayed accumulation of current flux upon continued application of glutamate.
Protein Name Glutamate Receptor 1
Glur-1
Ampa-Selective Glutamate Receptor 1
Glur-A
Glur-K1
Glutamate Receptor Ionotropic - Ampa 1
Glua1
Database Links Reactome: R-RNO-204005
Reactome: -RNO-399710
Reactome: -RNO-399719
Reactome: -RNO-416993
Reactome: -RNO-438066
Reactome: -RNO-5694530
Reactome: -RNO-8849932
Cellular Localisation Cell Membrane
Multi-Pass Membrane Protein
Endoplasmic Reticulum Membrane
Postsynaptic Cell Membrane
Postsynaptic Density Membrane
Cell Projection
Dendrite
Dendritic Spine
Early Endosome Membrane
Recycling Endosome Membrane
Presynapse
Synapse
Interaction With Cacng2
Cnih2 And Cnih3 Promotes Cell Surface Expression
Colocalizes With Pdlim4 In Early Endosomes
Displays A Somatodendritic Localization And Is Excluded From Axons In Neurons
Localized To Cone Photoreceptor Pedicles
Alternative Antibody Names Anti-Glutamate Receptor 1 antibody
Anti-Glur-1 antibody
Anti-Ampa-Selective Glutamate Receptor 1 antibody
Anti-Glur-A antibody
Anti-Glur-K1 antibody
Anti-Glutamate Receptor Ionotropic - Ampa 1 antibody
Anti-Glua1 antibody
Anti-Gria1 antibody
Anti-Glur1 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance